News

Public · Published

Argus Research maintains Thermo Fisher Scientific at Buy, raises price target to $780 from $560

Argus Research kept its Buy rating on Thermo Fisher Scientific and raised its price target to $780 from $560, a 39.3% increase. The new target implies 10.0% upside from the October 29 close of $709.18.

Published:

Updated:

What happened

Argus Research kept its Buy rating on Thermo Fisher Scientific and raised its price target to $780 from $560, a 39.3% increase. The new target implies 10.0% upside from the October 29 close of $709.18.

Confirmed

Global impact / market context

A higher price target signals that Argus expects Thermo Fisher's shares to be worth more than before. Because the new target sits above the recent closing price, it suggests the analyst sees further room for the stock to rise.

Analyst inference

Other analysts recently set Thermo Fisher targets between $730 and $810, so Argus's $780 fits within that range. This clustering suggests broad analyst agreement on the company's prospects, though price targets are opinions rather than guarantees of future performance.

Analyst inference

What to watch

  1. Watch whether other research firms change their Thermo Fisher ratings or price targets, since recent targets from five analysts ranged from $730 to $810. Confirmed
  2. Watch Thermo Fisher's revenue, profit per sale, and cash available in coming reports, because weaker results could prompt analysts to lower targets. Analyst inference
  3. Investors could compare the $780 target with the $709.18 reference close to judge the implied 10.0% upside before making any portfolio decision. Proposed

Evidence

  • Original source link unavailable